Anticancer peptide Q7 suppresses the growth and migration of human endometrial cancer

This study is to address an anticancer peptide, herein named Q7, which could downregulate 24- Dehydrocholesterol Reductase (DHCR24) to disrupt lipid rafts formation, and sequentially affect the AKT signal pathway of HEC-1-A cells to suppress their tumorigenicity such as proliferation and migration.